Human GNAI2/GIP/GNAI2B ORF/cDNA clone-Lentivirus plasmid (NM_002070)
Cat. No.: pGMLP000132
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human GNAI2/GIP/GNAI2B Lentiviral expression plasmid for GNAI2 lentivirus packaging, GNAI2 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.
Go to
GNAI2/GIP products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
| Catalog ID | pGMLP000132 |
| Gene Name | GNAI2 |
| Accession Number | NM_002070 |
| Gene ID | 2771 |
| Species | Human |
| Product Type | Lentivirus plasmid (overexpression) |
| Insert Length | 1068 bp |
| Gene Alias | GIP,GNAI2B,H_LUCA15.1,H_LUCA16.1 |
| Fluorescent Reporter | ZsGreen |
| Mammalian Cell Selection | Puromyocin |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGGGCTGCACCGTGAGCGCCGAGGACAAGGCGGCGGCCGAGCGCTCTAAGATGATCGACAAGAACCTGCGGGAGGACGGAGAGAAGGCGGCGCGGGAGGTGAAGTTGCTGCTGTTGGGTGCTGGGGAGTCAGGGAAGAGCACCATCGTCAAGCAGATGAAGATCATCCACGAGGATGGCTACTCCGAGGAGGAATGCCGGCAGTACCGGGCGGTTGTCTACAGCAACACCATCCAGTCCATCATGGCCATTGTCAAAGCCATGGGCAACCTGCAGATCGACTTTGCCGACCCCTCCAGAGCGGACGACGCCAGGCAGCTATTTGCACTGTCCTGCACCGCCGAGGAGCAAGGCGTGCTCCCTGATGACCTGTCCGGCGTCATCCGGAGGCTCTGGGCTGACCATGGTGTGCAGGCCTGCTTTGGCCGCTCAAGGGAATACCAGCTCAACGACTCAGCTGCCTACTACCTGAACGACCTGGAGCGTATTGCACAGAGTGACTACATCCCCACACAGCAAGATGTGCTACGGACCCGCGTAAAGACCACGGGGATCGTGGAGACACACTTCACCTTCAAGGACCTACACTTCAAGATGTTTGATGTGGGTGGTCAGCGGTCTGAGCGGAAGAAGTGGATCCACTGCTTTGAGGGCGTCACAGCCATCATCTTCTGCGTAGCCTTGAGCGCCTATGACTTGGTGCTAGCTGAGGACGAGGAGATGAACCGCATGCATGAGAGCATGAAGCTATTCGATAGCATCTGCAACAACAAGTGGTTCACAGACACGTCCATCATCCTCTTCCTCAACAAGAAGGACCTGTTTGAGGAGAAGATCACACACAGTCCCCTGACCATCTGCTTCCCTGAGTACACAGGGGCCAACAAATATGATGAGGCAGCCAGCTACATCCAGAGTAAGTTTGAGGACCTGAATAAGCGCAAAGACACCAAGGAGATCTACACGCACTTCACGTGCGCCACCGACACCAAGAACGTGCAGTTCGTGTTTGACGCCGTCACCGATGTCATCATCAAGAACAACCTGAAGGACTGCGGCCTCTTCTGA |
| ORF Protein Sequence | MGCTVSAEDKAAAERSKMIDKNLREDGEKAAREVKLLLLGAGESGKSTIVKQMKIIHEDGYSEEECRQYRAVVYSNTIQSIMAIVKAMGNLQIDFADPSRADDARQLFALSCTAEEQGVLPDDLSGVIRRLWADHGVQACFGRSREYQLNDSAAYYLNDLERIAQSDYIPTQQDVLRTRVKTTGIVETHFTFKDLHFKMFDVGGQRSERKKWIHCFEGVTAIIFCVALSAYDLVLAEDEEMNRMHESMKLFDSICNNKWFTDTSIILFLNKKDLFEEKITHSPLTICFPEYTGANKYDEAASYIQSKFEDLNKRKDTKEIYTHFTCATDTKNVQFVFDAVTDVIIKNNLKDCGLF |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-MP2143-Ab | Anti-GNAI2/ GIPB/ H_LUCA15.1 monoclonal antibody |
| Target Antigen | GM-Tg-g-MP2143-Ag | GNAI2 VLP (virus-like particle) |
| ORF Viral Vector | pGMLP000132 | Human GNAI2 Lentivirus plasmid |
| ORF Viral Vector | vGMLP000132 | Human GNAI2 Lentivirus particle |
Target information
| Target ID | GM-MP2143 |
| Target Name | GNAI2 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
2771 |
| Gene ID |
100062085 (Equus caballus), 101089679 (Felis catus), 14678 (Mus musculus), 2771 (Homo sapiens) 281791 (Bos taurus), 442957 (Canis lupus familiaris), 703780 (Macaca mulatta), 81664 (Rattus norvegicus) |
| Gene Symbols & Synonyms | GNAI2,Gnai2,HG1C,Gia,Hg1c,Gnai-2,Galphai2,GIP,GNAI2B,H_LUCA15.1,H_LUCA16.1 |
| Target Alternative Names | Adenylate cyclase-inhibiting G alpha protein,GIP,GNAI2,GNAI2B,Galphai2,Gia,Gnai-2,Gnai2,Guanine nucleotide-binding protein G(i) subunit alpha-2,HG1C,H_LUCA15.1,H_LUCA16.1,Hg1c |
| Uniprot Accession |
P04897,P04899,P08752,P38400
Additional SwissProt Accessions: P08752,P04899,P38400,P04897 |
| Uniprot Entry Name | |
| Protein Sub-location | Transmembrane Protein |
| Category | |
| Disease | cancer |
| Disease from KEGG | Rap1 signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Chemokine signaling pathway, Sphingolipid signaling pathway, Adrenergic signaling in cardiomyocytes, Axon guidance, Gap junction, Platelet activation, Leukocyte transendothelial migration, Circadian entrainment, Glutamatergic synapse, Cholinergic synapse, Serotonergic synapse, GABAergic synapse, Melanogenesis, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Relaxin signaling pathway, Parathyroid hormone synthesis, secretion and action, Cushing syndrome, Growth hormone synthesis, secretion and action, Gastric acid secretion, Cocaine addiction, Morphine addiction, Pertussis, Chagas disease, Toxoplasmosis, Human cytomegalovirus infection, Pathways in cancer, Chemical carcinogenesis - receptor activation |
| Gene Ensembl | ENSECAG00000000489, ENSMUSG00000032562, ENSG00000114353, ENSBTAG00000020645, ENSCAFG00845022609, ENSMMUG00000056280 |
| Target Classification | Tumor-associated antigen (TAA) |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


